Progesterone signaling in uterine fibroids: Molecular mechanisms and therapeutic opportunities.

Life Sci

Department of Gynecology and Obstetrics, Division of Reproductive Sciences & Women's Health Research, Johns Hopkins Medicine, Baltimore, MD 21205, USA. Electronic address:

Published: December 2024

Progesterone (P4) is a vital female sex hormone involved in various physiological processes, including the maintenance of the endometrium, mammary gland development, and bone health. Beyond its reproductive roles, P4 is implicated in the pathogenesis of hormone-dependent conditions like uterine fibroids, the most common benign tumors in women, which can severely affect quality of life and fertility. Traditionally, estrogen was considered the primary driver of fibroid growth, but recent research highlights the significant role of P4 in fibroid growth. P4 interacts with progesterone receptors (PRs) and non-genomic membrane receptors (mPRs and PGRMCs) to activate signaling pathways that enhance tumor growth and survival. P4 promotes vascular changes that improve the blood supply to fibroids and modifies the extracellular matrix, a key component of fibroid structure. This understanding has led to the investigation of selective progesterone receptor modulators (SPRMs) as potential therapies for fibroids. Clinical trials have demonstrated the effectiveness of SPRMs like mifepristone, asoprisnil, and ulipristal acetate in reducing fibroid size and symptoms, though concerns about safety, particularly with long-term use, remain. Newer SPRMs, such as vilaprisan, show promise, but further research is necessary to assess the long-term safety and effectiveness. This review discusses the mechanisms by which progesterone contributes to fibroid growth and examines clinical effectiveness of SPRMs as potential treatments for uterine fibroids.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lfs.2024.123345DOI Listing

Publication Analysis

Top Keywords

uterine fibroids
12
fibroid growth
12
sprms potential
8
effectiveness sprms
8
progesterone
5
fibroids
5
fibroid
5
progesterone signaling
4
signaling uterine
4
fibroids molecular
4

Similar Publications

Leuprolide acetate is commonly used to reduce the size of myomas before surgery. Initially, it stimulates pituitary gonadotropin secretion, followed by sustained suppression of gonadal function. However, the impact on pregnancy outcomes from inadvertent exposure remains unclear.

View Article and Find Full Text PDF

Background:  Uterine fibroids are benign gynecological tumours that arise in the uterine smooth muscle tissue and are characterized by the production of excessive quantities of extracellular matrix. Various therapeutic options, from medical management to surgical intervention, exist for uterine fibroids, for which homeopathy has emerged as a promising therapeutic option in patient-centered care.

Case History:  A 40-year-old woman presented with complaints of heavy menstrual bleeding, with pain in the pelvic region and back.

View Article and Find Full Text PDF

Uterine leiomyomas (uLMs) are the most prevalent benign tumors of the female reproductive system. MED12 is one of the mediator complex subunits that has been implicated in uLMs pathogenesis. Somatic mutations in exon2-MED12 have been found in ~ 70% of uLMs.

View Article and Find Full Text PDF

Robotic Surgery for Benign Hysterectomy: A Real-World Study From India.

Cureus

December 2024

Department of Gynecology and Obstetrics, Zydus Hospitals, Ahmedabad, IND.

Background In gynecology, hysterectomy is a common surgical procedure for benign conditions. This study was conducted to assess the short-term clinical outcomes of robotic-assisted hysterectomy in the Indian population. Methods We performed a retrospective chart review of patients who underwent robotic-assisted benign hysterectomy procedures between December 2021 and July 2024.

View Article and Find Full Text PDF

Impact of serum lipid on recurrence of uterine fibroids: a single center retrospective study.

BMC Womens Health

December 2024

Department of Gynecology, Ningbo Medical Center Lihuili Hospital, No.1111 Jiangnan Road, Yinzhou District, Ningbo, Zhejiang Province, 315040, China.

Background: We aimed to analyze the correlation between serum lipid levels [total cholesterol (TC), triglyceride (TG), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C)] and recurrence after uterine fibroids (UF) resection, and explore the predictive value of serum lipid levels in determining recurrence after myomectomy.

Methods: In this retrospective cohort study, 323 patients undergoing first myomectomy who came from Li Huili Hospital, Ningbo Medical Center between December 2019 and January 2023 were included. The primary endpoint was the recurrence of UF within 12 months following surgery.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!